Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Plos Pathogens|November 19, 2013
Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of macrophagesJulia Esser-von Bieren, Ilaria Mosconi, Romain Guiet, et al.The Journal of Experimental Medicine|March 20, 2002
Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibodySamareh Azeredo da Silveira, Shuichi Kikuchi, Liliane Fossati-Jimack, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 2012
Fcγ receptor IIb strongly regulates Fcγ receptor-facilitated T cell activation by dendritic cellsNadine van Montfoort, Peter A C 't Hoen, Sara M Mangsbo, et al.Cancers|June 2, 2021
Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in MiceRens Braster, Marijn Bögels, Hreinn Benonisson, et al.Journal of Leukocyte Biology|December 21, 2010
CD97 antibody depletes granulocytes in mice under conditions of acute inflammation via a Fc receptor-dependent mechanismHenrike Veninga, Dorien M de Groot, Natalie McCloskey, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2012
FcγRIIb on myeloid cells and intrinsic renal cells rather than B cells protects from nephrotoxic nephritisPhoebe E H Sharp, Javier Martin-Ramirez, Sara M Mangsbo, et al.Scientific Reports|March 5, 2020
Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatmentHeng Sheng Sow, Hreinn Benonisson, Conny Brouwers, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 7, 2018
High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody TherapyHreinn Benonisson, Heng Sheng Sow, Cor Breukel, et al.Arthritis and Rheumatism|January 31, 2009
Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritisLilyanne C Grevers, Peter L E M van Lent, Marije I Koenders, et al.Molecular Immunology|January 17, 2012
Increased incidence of anti-GBM disease in Fcgamma receptor 2b deficient mice, but not mice with conditional deletion of Fcgr2b on either B cells or myeloid cells alonePhoebe E H Sharp, Javier Martin-Ramirez, Peter Boross, et al.Pageof 10